Pandion Therapeutics Inc (PAND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PAND | TARS | CLDX | ||
| Company | Pandion Therapeutics Inc | Tarsus Pharmaceuticals Inc | Celldex Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 59.95 | 46.86 | 26.60 | ||
| High | 60.05 | 47.60 | 27.09 | ||
| Low | 59.95 | 45.19 | 26.28 | ||
| Last | 60.05 | 46.44 | 26.28 | ||
| Change | +0.13 | -0.14 | -0.12 | ||
| % Change | +0.22% | -0.30% | -0.45% | ||
| Volume | 241,500 | 301,180 | 400,229 | ||
| 20-Day Average Volume | 267,345 | 1,003,449 | 1,108,030 | ||
| Previous Close | 59.92 | 46.58 | 26.40 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 60.07 | 45.69 | 26.08 | ||
| 20-Day Raw Stochastic | 19.40% | 56.49% | 57.06% | ||
| 20-Day Relative Strength | 86.37% | 64.26% | 43.99% | ||
| Weighted Alpha | +75.62 | +156.89 | -31.29 | ||
| Today's Opinion | N/A | 88% Buy | 88% Sell | ||
| Previous Opinion | N/A | 88% Buy | 88% Sell | ||
| Last Month's Opinion | N/A | 88% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.13% since 03/24/21 | +0.23% since 11/14/24 | +3.38% since 11/14/24 | ||
| Low | 59.92 on 03/30/21 | 43.25 on 11/15/24 | 22.93 on 11/18/24 | ||
| High | 60.14 on 03/25/21 | 47.60 on 11/21/24 | 27.09 on 11/21/24 | ||
| 1-Month | |||||
| %Chg | -0.25% since 02/26/21 | +28.27% since 10/21/24 | -7.25% since 10/21/24 | ||
| Low | 59.60 on 03/04/21 | 36.07 on 10/22/24 | 22.93 on 11/18/24 | ||
| High | 62.90 on 03/02/21 | 52.99 on 11/14/24 | 29.38 on 10/28/24 | ||
| 3-Month | |||||
| %Chg | +297.42% since 12/28/20 | +79.28% since 08/21/24 | -26.25% since 08/21/24 | ||
| Low | 14.55 on 12/31/20 | 25.14 on 08/22/24 | 22.93 on 11/18/24 | ||
| High | 62.90 on 03/02/21 | 52.99 on 11/14/24 | 47.00 on 09/25/24 | ||
| 6-Month | |||||
| %Chg | +390.60% since 09/28/20 | +23.59% since 05/21/24 | -29.36% since 05/21/24 | ||
| Low | 10.28 on 10/28/20 | 20.08 on 08/05/24 | 22.93 on 11/18/24 | ||
| High | 62.90 on 03/02/21 | 52.99 on 11/14/24 | 47.00 on 09/25/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,772,436 | 1,780,614 | 1,751,482 | ||
| Shares Outstanding, K | 29,516 | 38,227 | 66,344 | ||
| Annual Sales | 8,780,000 | 17,450,000 | 6,880,000 | ||
| Annual Net Income | -38,110,000 | -135,890,000 | -141,430,000 | ||
| Last Quarter Sales | 2,630,000 | 48,120,000 | 3,190,000 | ||
| Last Quarter Net Income | -11,900,000 | -23,420,000 | -42,120,000 | ||
| 60-Month Beta | N/A | 1.00 | 1.60 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.61 on 11/13/24 | -0.64 on 11/06/24 | ||
| Latest Earnings Date | 04/05/21 | 11/13/24 | 11/07/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||